February 18, 2009
FINC 4210: Investments
Analyst Report 1: Abbott Laboratories
Abbott Laboratories was incorporated in 1990 in Illinois. The company manufactures, develops, and sells a variety of health care products. The company is divided into four major sectors which are pharmaceutical products, nutritional products, diagnostic products, and vascular products. The pharmaceutical products segment manufactures and sells adult and pediatric pharmaceuticals on a global scale. This segment directs its primary marketing efforts toward securing physician prescriptions and recommendations. Managed care providers, and state and federal agencies are also important customers. The diagnostic products segment sells diagnostic systems and tests directly to laboratories, hospitals, clinics and physicians' offices in the United States, and either directly or through distributors worldwide. The nutritional products segment sells baby formula, nutritional drinks and nutritional food items to institutions, wholesalers, retailers, health care facilities and government agencies. The vascular products segment develops products for the treatment of vascular disease. Products are sold directly to hospitals in the United States, and either directly or through distributors worldwide.
Pharmaceutical manufacturers produce a diverse range of preparations for human treatment. The majority of these firms' products are produced in final form for consumption such as ampoules, tablets, capsules, vials, ointments, medicinal powders, solutions, and suspensions. Industry output consists of two important lines. Pharmaceutical preparations promoted primarily to the dental, medical, or veterinary professions are called "ethical" drugs, also known as prescription drugs. Those sold openly to the public are commonly described as "over-the-counter" (OTC) drugs. There are loads of different pharmaceutical companies which...